Abstract
PURPOSE: This study was performed to determine whether endoanal ultrasound could be used to accurately stage patients with squamous-cell carcinoma of the anal canal and to determine the response of these tumors to multimodality therapy. METHODS: Thirteen consecutive patients with biopsy-proven squamous-cell carcinoma of the anal canal between 1996 and 1999 were included in the study. All patients underwent a pretreatment staging endoanal ultrasound with a B&K 3535 ultrasound machine using the 1850 rotating 360° probe with a 10-MHz transducer. Tumors were staged using our own modification of a 1984 TNM staging system. For our study, a uT1 tumor was confined to the submucosa; a uT2a lesion invaded only the internal anal sphincter; a uT2b lesion penetrated into the external anal sphincter; a uT3 lesion invaded through the sphincter complex into the perianal tissues; and a uT4 lesion invaded adjacent structures. After the initial study, patients decided on a course of treatment, either primary surgery or chemoradiation. For patients choosing chemoradiation, a clinical examination with biopsies and a repeat endoanal ultrasound was performed after completion of therapy. Findings on physical examination and biopsy results were compared with the follow-up endoanal ultrasound. For those choosing surgery, the pathology specimen from the abdominoperineal resection was reviewed and compared with the initial endoanal ultrasound interpretation to determine the accuracy of endoanal ultrasound staging. RESULTS: One patient died of complications from acquired immunodeficiency syndrome before undergoing definitive treatment for his anal cancer. Of the remaining 12 patients who comprised the study, the endoscopic staging was as follows: 1 uT1, 5 uT2a, 3 uT2b, 2 uT3, and 1 uT4. Five of the 12 patients selected surgery as the primary treatment modality for their disease. The other seven patients underwent a full course of chemoradiation. In all five patients who had an abdominoperineal resection, the surgical staging correlated with the endoanal ultrasound staging (2 T2a tumors and 3 T2b tumors). In the remaining seven patients, six to eight weeks after completion of therapy, there was no evidence of residual tumor by clinical examination and biopsies. In one of the seven patients, no abnormalities were detected on endoanal ultrasound, and it was interpreted as normal with no evidence of disease. In the remaining six patients, endoanal ultrasound revealed abnormalities that were judged to represent radiation-induced changes rather than residual disease. A repeat endoanal ultrasound was done in these patients two to four months after the biopsies. Complete resolution of the postradiation changes occurred in all patients, and the scans were interpreted as showing no evidence of disease. CONCLUSIONS: Endoanal ultrasound can accurately determine the depth of penetration of squamous-cell carcinoma into the sphincter complex and can be used to gauge accurately the response of these tumors to chemoradiation therapy. Our newly proposed ultrasound staging system may be more useful in choosing treatment options; future studies should be aimed at using endoanal ultrasound in identifying early lesions that may be amenable to less aggressive therapy as well as determining the utility of ultrasound in the surveillance of patients after successful treatment of their initial tumors.
Similar content being viewed by others
References
RT Greenlee T Murray S Bolden PA Wingo (2000) ArticleTitleCancer statistics, 2000. CA Cancer J Clin 50 7–33
DP Ryan CC Compton R Mayer (2000) ArticleTitleCarcinoma of the anal canal. N Engl J Med 342 792–800
M Frisch B Glimelius AJ Vanden Brule et al. (1997) ArticleTitleSexually transmitted infection as a cause of anal cancer. N Engl J Med 337 1350–1358
ND Nigro VK Vaitkevicius B Considine (1974) ArticleTitleCombined therapy for cancer of the anal canal: Dis Colon Rectum 17 354–356
KI Deen RD Madoff C Belmonte WD Wong (1995) ArticleTitlePreoperative staging of rectal neoplasms with endorectal ultrasonography. Semin Colon Rectal Surg 6 78–85
GJ Blatchford (1995) ArticleTitleAnal ultrasonography in the evaluation of fecal incontinence. Semin Colon Rectal Surg 6 99–104
JG Williams (1995) ArticleTitleAnal ultrasonography in the diagnosis and management of abscess and fistula disease of the anorectum. Semin Colon Rectal Surg 6 105–113
M Chadha EA Rosenblatt S Malamud J Pisch A Berson (1994) ArticleTitleSquamous-cell carcinoma of the anus in HIV-positive patients. Dis Colon Rectum 37 861–865
JM Holland PS Swift (1994) ArticleTitleTolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy. Radiology 193 251–254
U Herzog M Boss HP Spichtin (1994) ArticleTitleEndoanal ultrasonography in the follow-up of anal carcinoma. Surg Endosc 8 1186–1189
G Roseau L Palazzo P Colardelle S Chaussade D Couturier JA Paolaggi (1994) ArticleTitleEndoscopic ultrasonography in the staging and follow-up of epidermoid carcinoma of the anal canal. Gastrointest Endosc 40 447–450
B Magdeburg M Fried C Meyenberger (1999) ArticleTitleEndoscopic ultrasonography in the diagnosis, staging, and follow-up of anal carcinomas. Endoscopy 31 359–364
CO Finne (1995) ArticleTitleThe role of endorectal sonography in the follow-up of malignant diseases of the anorectum. Semin Colon Rectal Surg 6 86–93
S Goldman B Glimelius U Norming L Påhlman U Seligson (1988) ArticleTitleTransanorectal ultrasonography in anal carcinoma: Acta Radiol 29 337–341
S Goldman U Norming C Svennson B Glimelius (1991) ArticleTitleTransanorectal ultrasonography in the staging of anal epidermoid carcinoma. Int J Colorectal Dis 6 152–157
P Paradis HO Douglas ED Holyoke (1975) ArticleTitleThe clinical implications of a staging system for carcinoma of the anus. Surg Gynecol Obstet 141 411–416
R Singh F Nime A Mittelman (1981) ArticleTitleMalignant epithelial tumors of the anal canal. Cancer 48 411–414
DB Frost PC Richards ED Montague GG Giacco RG Martin (1984) ArticleTitleEpidermoid cancer of the anorectum. Cancer 53 1285–1293
MJ Greenall SH Quan C Urmacher JJ DeCosse (1985) ArticleTitleThe treatment of epidermoid carcinoma of the anal canal. Surg Gynecol Oncol 161 509–517
M Flam M John T Pajak et al. (1996) ArticleTitleRole of mitomycin C with fluorouracil and radiotherapy and salvage chemoradiation in the definitive non-surgical treatment of epidermoid carcinoma of the anal canal: J Clin Oncol 14 2527–2539
H Bartelink F Roelofsen F Eschwege et al. (1997) ArticleTitleConcomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: J Clin Oncol 15 2040–2049
BM Boman CG Moertel MJ O’Connell et al. (1984) ArticleTitleCarcinoma of the anal canal: Cancer 54 114–125
D Vordermark M Sailer M Flentje A Thiede O Kolbl (1999) ArticleTitleCurative-intent radiation therapy in anal carcinoma: Radiother Oncol 52 239–243
R Koffman ML Welton B Klencke V Weinberg R Krieg (1999) ArticleTitleThe significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys 44 127–131
EJ Miller SH Quan HT Thaler (1991) ArticleTitleTreatment of squamous cell carcinoma of the anal canal. Cancer 67 2038–2041
Author information
Authors and Affiliations
About this article
Cite this article
Tarantino, D., Bernstein, M.A. Endoanal Ultrasound in the Staging and Management of Squamous-Cell Carcinoma of the Anal Canal. Dis Colon Rectum 45, 16–22 (2002). https://doi.org/10.1007/s10350-004-6108-1
Issue Date:
DOI: https://doi.org/10.1007/s10350-004-6108-1